E1304 E1304 (Chlorpheniramine and pseudoephedrine 8 mg / 120 mg)
Pill imprint E1304 E1304 has been identified as Chlorpheniramine and pseudoephedrine 8 mg / 120 mg.
Chlorpheniramine/pseudoephedrine is used in the treatment of allergic rhinitis; sinusitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Chlorpheniramine/pseudoephedrine 8 mg / 120 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- E1304 E1304
- Strength:
- 8 mg / 120 mg
- Color:
- Blue / Clear
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-1304
More about chlorpheniramine/pseudoephedrine
Consumer resources
- Chlorpheniramine/pseudoephedrine
- Chlorpheniramine/pseudoephedrine 24-hour sustained-release capsules
- Chlorpheniramine/pseudoephedrine chewable tablets
- Chlorpheniramine/pseudoephedrine controlled-release capsules
- Chlorpheniramine/pseudoephedrine liquid
- More (4) »
- Other brands: Deconamine, LoHist-D, Histade CR, Novafed A, More (9) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
